Related Experiment Video
Updated: Sep 7, 2025

Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies
Published on: February 3, 2023
Self-reported compliance with drug therapy during the first SARS-CoV-2 Italian lockdown in patients with respiratory
Rosastella Principe1, Loreta Di Michele1, Alfredo Sebastiani1
1Day Hospital Pneumologico e Interstiziopatie Polmonari, Ospedale San Camillo-Forlanini, Rome, Italy.
Background:
Low compliance with drug therapy in patients with chronic respiratory diseases was a well-known issue even before the coronavirus pandemic, but its causes are not yet fully defined.
Objective:
To verify the adherence to drug therapy in patients with respiratory disease during the COVID-19 pandemic.
Methods:
From June to September 2020, about 700 patients of the Forlanini Hospital who had been unmonitored during the March-May 2020 lockdown in Italy received a questionnaire during the pneumological check-up based on self-reported information on compliance with therapy during lockdown.
Results:
284 out of the 418 returned questionnaires could be used in this study: 179 patients (63.0%) responded positively to the continuation of therapy, 18 (6.3%) reduced the dosage of their medication and 82 (28.9%) interrupted the therapy.
Conclusions:
The low percentage of patients that reduced their drug dosage may be due to an increased awareness of drug treatment benefits, and may also be ascribed to the Government healthcare strategy during lockdown.
More Related Videos
Related Concept Videos
Drug Therapy
Antianxiety Medications
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Factors Affecting Drug Response: Overview
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation

